Metformin treatment also reduced BALF levels of CCL17 and CCL2, cytokines we previously reported as being upregulated in AT2I73T cells and increased in the SftpcI73T mouse model of lung fibrosis (18) (Figure 7I). This evidence concerns the gene CCL2 and pulmonary fibrosis.